Charles W. Tate was appointed to the Oversight Committee by Lt. Governor David Dewhurst on June 20, 2008. Mr. Tate serves on the executive committee of the Oversight Committee, as well as chairing the Economic Development and Commercialization subcommittee. His lifelong venture capital experience informs much of the work that he does with CPRIT to establish and promote commercialization initiatives. Mr. Tate is the chairman and founder of Capital Royalty, LP., a private equity firm targeting investments in the healthcare industry. Capital Royalty, headquartered in Houston, provides capital to the healthcare industry by acquiring royalty and net revenue interests in ethical pharmaceuticals or medical devices from royalty holders or biotechnology/pharmaceutical companies needing either liquidity or capital for developmental purposes.
Prior to forming Capital Royalty, Mr. Tate was a partner and member of the Management Committee of Hicks, Muse, Tate & Furst Incorporated, until his retirement at the end of June 2002. He joined Hicks Muse in 1991 and has more than 35 years experience in investment and merchant banking. Prior to joining Hicks Muse, Mr. Tate was at Morgan Stanley & Co. for 19 years, most of that time as a Managing Director in the firm’s mergers and acquisitions department, and for the last two-and-a-half years in its Merchant Banking area. Before joining Morgan Stanley, Mr. Tate was employed by the Bank of America in New York from 1968 to 1971.
Mr. Tate serves on The University Cancer Foundation Board of Visitors for M. D. Anderson Cancer Center and is a member of the Strategic Advisory Committee and Chairman of the Center for Global Oncology Advisory Group. Mr. Tate serves as Chairman of the External Advisory Committee of the Department of Biomedical Engineering at The University of Texas at Austin, U.T.’s M.D. Anderson Cancer Center and U.T.’s Health Science Center, the latter two located in Houston. Mr. Tate served during 2004 on The University of Texas Commission of 125 and was a Member of the Executive Committee.
He also serves on the Industry and Community Affiliates Committee of The Academy of Medicine, Engineering and Science of Texas.
During 2002, Mr. Tate served on Governor Rick Perry’s Council for Science and Biotechnology Development and was Chairman of the Committee on Capital Formation. In September 2005, Mr. Tate became Chairman of the Texas Life Science Center of Innovation and Commercialization as part of the advisory structure for the State’s Emerging Technology Fund.
Since September 2004, Mr. Tate has served as a Director of The University of Texas Investment Management Co. (“UTIMCO”), and since January 2008 he has served on The Robert A. Welch Foundation Board of Directors. Additionally, in 2007, he was elected a Distinguished Alumnus of The University of Texas. He also currently serves on the Board of Overseers of the Columbia University Graduate School of Business.
Mr. Tate received his B.B.A. from The University of Texas at Austin in 1968 and his M.B.A. from Columbia University Graduate School of Business in 1972. Mr. Tate was elected to The University of Texas at Austin McCombs School of Business Hall of Fame in 2003.